Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
life sciences
national blog main
boston blog main
clinical trials
fda
san francisco blog main
agtechfood
alprazolam
amgen
antibodies
biologic drugs
boulder/denver
boulder/denver blog main
boulder/denver top stories
california life sciences association (clsa)
cgrp inhibitors
chronic migraine
clostridium difficile
colostrum
colucid pharmaceuticals
crohn's disease
cvs
cvs health
deals
diaresq
drug enforcement administration
drugs
eli lilly
fda warning letter
indiana
indiana blog main
indiana top stories
inflammatory bowel disease
investing
lasmiditan
mark braman
medical foods
microbiome
migraine research foundation
What
giving
3
×
new
acute
addresses
approval
babies
better
birth
born
breastfeed
california
causes
clinicians
community
companies
condition
days
decades
devices
diagnostics
disease
drug
education
eli
established
fda
fight
friday
fueled
giant
gut
instructed
lands
lasmiditan
life
lilly
lilly’s
medication
medicines
microbiome
Language
unset
Current search:
giving
×
biotech
×
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
4 years ago
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
@xconomy.com
4 years ago
California Life Sciences Fueled by Education, Established Companies